Your browser doesn't support javascript.
loading
Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment Initiation.
Mathur, Deepti; Taylor, Bradford P; Chatila, Walid K; Scher, Howard I; Schultz, Nikolaus; Razavi, Pedram; Xavier, Joao B.
Afiliação
  • Mathur D; Program for Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Taylor BP; Program for Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chatila WK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Scher HI; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Schultz N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Razavi P; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Xavier JB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Mol Cancer Ther ; 21(5): 831-843, 2022 05 04.
Article em En | MEDLINE | ID: mdl-35247928
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article